BRAF | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Regulatory

4 April 2024

Erasca heads for phase 3 at last

Regulatory

13 November 2023

November's CHMP meeting sets up a GSK-Novartis battle

Novartis' Jakafi faces competition from GSK's momelotinib, while Astra looks over its shoulder at Merck in biliary tract cancer.

Trial results

19 September 2023

The bad news just keeps coming for Kinnate

Subscribe to BRAF